Crossmark

Eculizumab as a therapeutic option for patients with scleroderma renal crisis associated with hemolytic uremic syndrome

Crossref DOI link: https://doi.org/10.1016/j.rcreue.2019.08.002

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Miranda Bucheli, Alfredo

Mora Alfonso, Sergio

Saldarriaga Rivera, Lina María
License Information

Text and Data Mining valid from 2020-07-01
More Information

This article is maintained by: Elsevier

Article Title: Eculizumab as a therapeutic option for patients with scleroderma renal crisis associated with hemolytic uremic syndrome

Journal Title: Revista Colombiana de Reumatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreue.2019.08.002

Content Type: simple-article

Copyright: © 2019 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.